GeNeuro Announces Recruitment of First Patients in All Five Swiss Centers in the First Personalized Medicine Clinical Trial Against Long-COVID Assessing Temelimab Read more about GeNeuro Announces Recruitment of First Patients in All Five Swiss Centers in the First Personalized Medicine Clinical Trial Against Long-COVID Assessing Temelimab
ALSTOM SA: Availibility of the half-year financial report as at 30 September 2022 Read more about ALSTOM SA: Availibility of the half-year financial report as at 30 September 2022
ALSTOM SA: Half year financial report 2022/23 Read more about ALSTOM SA: Half year financial report 2022/23
ALSTOM SA: Alstom’s first half 2022/23: solid results with full-year outlook and mid-term targets confirmed, backed by a resilient business model. Read more about ALSTOM SA: Alstom’s first half 2022/23: solid results with full-year outlook and mid-term targets confirmed, backed by a resilient business model.
Voltalia announces the launch of a capital increase with shareholders’ preferential subscription rights in the amount of approximately 490 million euros Read more about Voltalia announces the launch of a capital increase with shareholders’ preferential subscription rights in the amount of approximately 490 million euros
Nel ASA: Nel and GM collaborate on cost competitive renewable hydrogen production Read more about Nel ASA: Nel and GM collaborate on cost competitive renewable hydrogen production